Article info

Download PDFPDF
Concise report
Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)

Authors

  1. Correspondence to Professor Arthur Kavanaugh, Department of Rheumatology, University of California-San Diego, 9500 Gilman Drive, MC 0943, La Jolla, CA 92093-0943, USA; akavanaugh{at}ucsd.edu
View Full Text

Citation

Kavanaugh A, Puig L, Gottlieb AB, et al
Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)

Publication history

  • Received December 20, 2015
  • Revised March 2, 2016
  • Accepted March 24, 2016
  • First published April 20, 2016.
Online issue publication 
October 11, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.